Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BSD Medical Corp has received a warning letter from the FDA relating to errors in the conduct of clinical study at a single investigational site.
Subscribe to our email newsletter
The warning letter addresses three general areas: monitoring, securing investigator compliance with the protocol and reporting, the company said.
Medical systems developer BSD added that the concerns outlined by the FDA are limited to clinical study conduct and have nothing to do with the safety, efficacy, quality, design or manufacture of the company's equipment. The research site has been closed to treating patients since August 31, 2006.
The Salt Lake City-based company said that it intends to provide the FDA with a complete report of the actions taken in response to the letter.